MX2019013038A - Biocatalizadores nanoestructurados y biocompatibles para su uso en el tratamiento del cancer. - Google Patents

Biocatalizadores nanoestructurados y biocompatibles para su uso en el tratamiento del cancer.

Info

Publication number
MX2019013038A
MX2019013038A MX2019013038A MX2019013038A MX2019013038A MX 2019013038 A MX2019013038 A MX 2019013038A MX 2019013038 A MX2019013038 A MX 2019013038A MX 2019013038 A MX2019013038 A MX 2019013038A MX 2019013038 A MX2019013038 A MX 2019013038A
Authority
MX
Mexico
Prior art keywords
nanostructured
cancer treatment
biocatalysts
biocompatible
biocompatible biocatalysts
Prior art date
Application number
MX2019013038A
Other languages
English (en)
Inventor
María López Goerne Tessy
Original Assignee
Wenceslao Gomez Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenceslao Gomez Lopez filed Critical Wenceslao Gomez Lopez
Publication of MX2019013038A publication Critical patent/MX2019013038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Biocatalizadores nanoestructurados y biocompatibles, un ligando organico lineal o ramificado a compuestos basados en Pt, Cu o Fe, en estado de oxidacion II, III o IV, que tienen actividad citotoxica para su uso en el tratamiento del cancer en animales o humanos.
MX2019013038A 2017-07-20 2018-07-18 Biocatalizadores nanoestructurados y biocompatibles para su uso en el tratamiento del cancer. MX2019013038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762534748P 2017-07-20 2017-07-20
PCT/IB2018/055335 WO2019016723A2 (en) 2017-07-20 2018-07-18 NANOSTRUCTURED AND BIOCOMPATIBLE BIOCATALYSTS FOR TREATING CANCER

Publications (1)

Publication Number Publication Date
MX2019013038A true MX2019013038A (es) 2019-12-18

Family

ID=65015666

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013038A MX2019013038A (es) 2017-07-20 2018-07-18 Biocatalizadores nanoestructurados y biocompatibles para su uso en el tratamiento del cancer.

Country Status (14)

Country Link
US (1) US20200147029A1 (es)
EP (1) EP3654949A4 (es)
JP (1) JP2020528083A (es)
KR (1) KR20200090733A (es)
CN (1) CN111093636A (es)
BR (1) BR112020001043A2 (es)
CA (1) CA3070320A1 (es)
CL (1) CL2020000130A1 (es)
CO (1) CO2020001813A2 (es)
EC (1) ECSP20013309A (es)
MX (1) MX2019013038A (es)
PE (1) PE20200753A1 (es)
SG (1) SG11202000509PA (es)
WO (1) WO2019016723A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3104725A1 (en) * 2018-05-21 2019-11-28 Innovasion Labs Pinc, Inc. Parallel integrated nano components (pinc) & related methods and devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2020987B1 (en) * 2006-06-06 2013-10-30 Universidad Autónoma Metropolitana Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
WO2010150036A1 (en) * 2009-06-24 2010-12-29 Universidad Autonoma Metropolitana - Xochimilco Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment
WO2011045627A1 (en) * 2009-10-12 2011-04-21 Arce Macias, Carlos, Francisco Viricide agents having nanostructured biocatalysts materials of titanium dioxide (tio2) and silicium dioxide (si02) with platinum and iridium modified and dispersed on the surface
US9034882B2 (en) * 2012-03-05 2015-05-19 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
MX339086B (es) * 2013-06-20 2016-05-09 Inmolecule Internat Ltd Nanomaterial de dioxido de titanio nanoparticulado modificado con grupos funcionales y con extractos citricos adsorbidos en la superficie para la eliminacion de amplio espectro de microorganismos.

Also Published As

Publication number Publication date
SG11202000509PA (en) 2020-02-27
JP2020528083A (ja) 2020-09-17
US20200147029A1 (en) 2020-05-14
CN111093636A (zh) 2020-05-01
KR20200090733A (ko) 2020-07-29
CO2020001813A2 (es) 2020-05-29
PE20200753A1 (es) 2020-07-27
EP3654949A2 (en) 2020-05-27
ECSP20013309A (es) 2020-09-30
CA3070320A1 (en) 2019-01-24
CL2020000130A1 (es) 2020-11-20
BR112020001043A2 (pt) 2020-07-21
EP3654949A4 (en) 2021-08-25
WO2019016723A2 (en) 2019-01-24
WO2019016723A3 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
MX2018001671A (es) Anticuerpos pd-1.
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
MX2019011825A (es) Tratamiento de enfermedades inflamatorias con inhibidores de actividad de c5a.
PH12017501646A1 (en) Antimicrobial compounds and methods of making and using the same
BR112021011289A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo weissella cibaria wikim28 como ingrediente ativo
BR112020009655A8 (pt) Anticorpo, usos de um anticorpo e uso de uma combinação farmacêutica
MX2022010638A (es) Inhibidores de pde9 para el tratamiento de enfermedades perifericas.
CU20120042A7 (es) (heteroarilmetil)tiohidantoínas sustituidas como drogas anticáncer
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
MX359210B (es) Composición de combinación de pac-1 y tamoxifeno.
MX2015014713A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cancer.
TN2015000406A1 (en) Antimicrobial compositions and related methods of use
MX359743B (es) Compuestos antimicrobianos y métodos para fabricar y utilizar los mismos.
UA118278C2 (uk) Гідроксиформамідні похідні та їх застосування
TR201905392T4 (tr) Ağrı tedavisi.
WO2018208954A3 (en) Peptidomimetic macrocycles and uses thereof
MX2019013038A (es) Biocatalizadores nanoestructurados y biocompatibles para su uso en el tratamiento del cancer.
BR112021011293A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo
WO2015042446A3 (en) Compositions and methods for the analysis of radiosensitivity
ZA202200273B (en) Animal food composition
PH12018502568A1 (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
WO2013121026A3 (en) Intermittent treatment with oxidizing and reducing agents
AU2014353885A8 (en) Prevention and treatment of toxicosis
WO2016068647A3 (ko) 광음향 조영효과 및 항암효과를 나타내는 알부민 나노입자